Search research articles
Contact Us
Filters
Showing results (331-340 of 445) with videos related to
Page
of 45
Sort By:
Iscience
|
November 15, 2023
Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors
Pranshu Sahgal, Deepa T Patil, Pratyusha Bala, et al.
The American Journal of Surgical Pathology
|
May 10, 2024
Transcriptionally Active Human Papillomavirus Infection in a Minority of Esophageal Squamous Cell Carcinomas in North America
Anna H Bauer, Khaled J Alkhateeb, Agoston T Agoston, et al.
Journal of Community Psychology
|
January 15, 2025
Community Implementation and Evaluation of the Chicago Parent Program
Robert T Ammerman, Cynthia Zion, Olivia M Cleary, et al.
Molecular Immunology
|
April 13, 1999
A single gene for human TRAF-3 at chromosome 14q32.3 encodes a variety of mRNA species by alternative polyadenylation, mRNA splicing and transcription initiation
W G van Eyndhoven, D Frank, S Kalachikov, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 17, 2022
Doing Genetic and Genomic Biology Using the Legume Information System and Associated Resources
Sven Redsun, Sam Hokin, Connor T Cameron, et al.
Stem Cells (Dayton, Ohio)
|
January 15, 2016
Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes
Matthew R Livesey, Dario Magnani, Elaine M Cleary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
A Phase I, dose-finding study in patients with advanced solid malignancies of the oral γ-secretase inhibitor PF-03084014
Wells A Messersmith, Geoffrey I Shapiro, James M Cleary, et al.
Plos One
|
August 18, 2017
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
Matthew E Randolph, Megan M Cleary, Zia Bajwa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2013
Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors
Leena Gandhi, Rastislav Bahleda, Sara M Tolaney, et al.
Oncotarget
|
October 4, 2017
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
Narendra Bharathy, Matthew N Svalina, Teagan P Settelmeyer, et al.
Page
of 45
Search research articles
Search
Showing results (331-340 of 445) with videos related to
Sort By:
Page
of 45
Iscience
|
November 15, 2023
Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors
Pranshu Sahgal, Deepa T Patil, Pratyusha Bala, et al.
The American Journal of Surgical Pathology
|
May 10, 2024
Transcriptionally Active Human Papillomavirus Infection in a Minority of Esophageal Squamous Cell Carcinomas in North America
Anna H Bauer, Khaled J Alkhateeb, Agoston T Agoston, et al.
Journal of Community Psychology
|
January 15, 2025
Community Implementation and Evaluation of the Chicago Parent Program
Robert T Ammerman, Cynthia Zion, Olivia M Cleary, et al.
Molecular Immunology
|
April 13, 1999
A single gene for human TRAF-3 at chromosome 14q32.3 encodes a variety of mRNA species by alternative polyadenylation, mRNA splicing and transcription initiation
W G van Eyndhoven, D Frank, S Kalachikov, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 17, 2022
Doing Genetic and Genomic Biology Using the Legume Information System and Associated Resources
Sven Redsun, Sam Hokin, Connor T Cameron, et al.
Stem Cells (Dayton, Ohio)
|
January 15, 2016
Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes
Matthew R Livesey, Dario Magnani, Elaine M Cleary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
A Phase I, dose-finding study in patients with advanced solid malignancies of the oral γ-secretase inhibitor PF-03084014
Wells A Messersmith, Geoffrey I Shapiro, James M Cleary, et al.
Plos One
|
August 18, 2017
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
Matthew E Randolph, Megan M Cleary, Zia Bajwa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2013
Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors
Leena Gandhi, Rastislav Bahleda, Sara M Tolaney, et al.
Oncotarget
|
October 4, 2017
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
Narendra Bharathy, Matthew N Svalina, Teagan P Settelmeyer, et al.
Page
of 45